-
Debate weighs whether BMI should remain central to obesity diagnosis
Francesco Rubino, MD, spoke in favor of moving beyond body mass index in diagnosing obesity. Leigh Perreault, MD, defended the long-time cornerstone of obesity diagnosis.
-
GLP-1 RA use, technology, unique needs of individuals are recurring themes in the latest updates to the Standards of Care in Diabetes
Six panelists, including Elizabeth Ann Beverly, PhD, explained the latest additions and changes within selected chapters to the Standards of Care in Diabetes—2026, the gold standard in evidence-based guidelines for diagnosing and managing diabetes and prediabetes.
-
Glucagon/GLP-1 receptor dual agonist demonstrates efficacy for obesity and MASLD
Matthias H. Tschöp, MD, and other researchers detailed phase 3 results of SYNCHRONIZE-1 and SYNCHRONIZE-MASLD showing that survodutide leads to significant weight loss, reduction in liver fat, and other health improvements.
-
Panel to offer strategies for supporting psychological wellbeing for women and girls with diabetes
Paige Trojanowski, PhD, and other panelists will present the latest findings on unique diabetes challenges during female adolescence, pregnancy, postpartum, parenting, menopause, and hormone replacement therapy.
-
Session to address the economic and health value of obesity treatment
Panelists, including Tim Dall, MS, will help make business and social cases for investing in evidence-based treatment for obesity, such as lower healthcare costs, improved quality of life, and reduced mortality.
-
Diabetes Journal symposium to explore non-classical complications of diabetes
Norbert Stefan, MD, PhD, and three other panelists will present the latest findings on how complications such as metabolic dysfunction-associated steatotic liver disease (MASLD), infections, cancer, and diastolic dysfunction are impacting individuals living with diabetes.
-
Panelists to outline impact of youth substance use on diabetes care
Elissa Weitzman, ScD, MSc, will be part of a trio of presenters in an Ask the Experts session focused on how to integrate conversations about the use of tobacco, alcohol, cannabis, pain medications, and other substances into clinical care for young people living with diabetes.
-
Panel to review the impact of disordered eating in diabetes and obesity
Nicole Patience, MS, RDN, LDN, CEDS-C, CDCES, and other experts will explain how eating disorders and imbalanced eating can affect people living with diabetes or obesity and how to help them achieve sustainable wellness.
-
Obesity Year in Review to give an overview of major advances and discoveries
Presentations in this opening-day symposium will include a review of recent literature on the clinical application of glucagon-like peptide-1 (GLP-1)-based drugs by Julio E. Ayala, PhD, who will also identify knowledge gaps that can guide future clinical trials.
-
Presenter Profile: Recharging Renal Energy: Novel Therapies for Mitochondrial Dysfunction in Diabetic Kidney Disease
Prabhleen (Sheena) Singh, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 4:30 p.m. CT.